[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_19664 

# __Lack of capacity for local vaccine production__

## Articles mentionning the risk

* [Lawal_covid-19_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_676.md)

## Mitigations of this risk

* [Investing in local production capabilities, technology transfer, research and development](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_21642.md)

## Name of the risk

Vulnerability to disease outbreaks, limited access to vaccines

## People affected by this risk

* [Countries with limited vaccine production capacity](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_15202.md)

## Stakeholders who can mitigate this risk

* [Global health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_47.md)
* [Governments](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_857.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Local vaccine production technology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_21977.md)
* [Technology transfer programs](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_21979.md)

## This Risk belongs to this RiskGroup

* [Infrastructure risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_2.md)

## This Risk belongs to this RiskSubgroup

* [Insufficient adoption of health-focused building standards](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_56.md)

